Dermatological Tumours

Real-world outcomes in patients with melanoma brain metastasis: a US multisite retrospective chart review study of systemic treatments
Isabella C Glitza Oliva, Jennell Palaia, Leon A Sakkal, Divya Patel, Andriy Moshyk, Natalia Han, Shardul Odak, Jordana K Schmier, Ning Ning, Sunandana Chandra

BMJ Open Jan 2025, 15 (1) e091098; DOI: 10.1136/bmjopen-2024-091098
Characterising melanoma diagnostic pathways for patients in routine practice using administrative health data in Ontario, Canada: a population-based study
Meaghan E Mavor, Patti A Groome, Yuka Asai, Hugh Langley, Nicole J Look Hong, Frances C Wright, Timothy P Hanna

BMJ Open Jan 2025, 15 (1) e086140; DOI: 10.1136/bmjopen-2024-086140
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study
Zhuohan Wu, Brooke Nickel, Farzaneh Boroumand, David Elder, Peter M Ferguson, Richard A Scolyer, Blake O'Brien, Raymond Barnhill, Adewole S Adamson, Alexander C J van Akkooi, Jon Emery, Lisa Parker, Donald Low, Cynthia Low, Elspeth Davies, Sherrie Liu, Stacey Lewis, Bella Spongberg-Ross, Katy JL Bell

BMJ Open Dec 2024, 14 (12) e089558; DOI: 10.1136/bmjopen-2024-089558
Prediction of relative survival trends in patients with cutaneous squamous cell carcinoma using a model-based period analysis: a retrospective analysis of the surveillance, epidemiology, and end results database
Suzheng Zheng, Hai Yu, Jinrong Zhang, Wai Chi Lau, Ming Chen, Hongtao Cheng, Hua Xian, Wai-kit Ming, Leong Nga Cheng, Yong He, Shuli Huang, Wenhui Chen, Jun Lyu, Liehua Deng

BMJ Open Dec 2024, 14 (12) e086488; DOI: 10.1136/bmjopen-2024-086488
Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study
Chia-Chi Lin, Giuseppe Curigliano, Armando Santoro, Dong-Wan Kim, David Tai, F Stephen Hodi, Sofie Wilgenhof, Toshihiko Doi, Catherine Sabatos-Peyton, Sebastian Szpakowski, Shripad Chitnis, Alexandros Xyrafas, Sabine Gutzwiller, Alessandro Pastore, Nicolas Mach

BMJ Open Aug 2024, 14 (8) e079132; DOI: 10.1136/bmjopen-2023-079132
PRESOLRE: study protocol for a primary school-based, cluster randomised controlled trial of three sun exposure risk prevention strategies on Reunion Island
Charline Dugast, Léa Bruneau, Adrian Fianu, Cyril Ferdynus, Karim Boussaid, Juliette Vuichard, Floreana Duloutre, Jessica Dumez, Nathalie Sultan-Bichat, Antoine Bertolotti

BMJ Open May 2024, 14 (5) e082045; DOI: 10.1136/bmjopen-2023-082045
Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review
Tafadzwa Patience Kunonga, R P W Kenny, Margaret Astin, Andrew Bryant, Vasileios Kontogiannis, Diarmuid Coughlan, Catherine Richmond, Claire H Eastaugh, Fiona R Beyer, Fiona Pearson, Dawn Craig, Penny Lovat, Luke Vale, Robert Ellis

BMJ Open Sep 2023, 13 (9) e073306; DOI: 10.1136/bmjopen-2023-073306
Perioperative treatment with tranexamic acid in melanoma (PRIME): protocol for a Danish multicentre randomised controlled trial investigating the prognostic and treatment-related impact of the plasminogen–plasmin pathway
Karoline Assifuah Kristjansen, Andreas Engel Krag, Henrik Schmidt, Lisbet Rosenkrantz Hölmich, Marie Louise Bønnelykke-Behrndtz

BMJ Open Feb 2024, 14 (2) e077012; DOI: 10.1136/bmjopen-2023-077012
BioMEL: a translational research biobank of melanocytic lesions and melanoma
Teo Helkkula, Gustav Christensen, Christian Ingvar, Karolin Isaksson, Katja Harbst, Bertil Persson, Åsa Ingvar, Anna Hafström, Ana Carneiro, Viktoria Gaspar, Göran Jönsson, Kari Nielsen

BMJ Open Feb 2024, 14 (2) e069694; DOI: 10.1136/bmjopen-2022-069694
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A₂ inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial
Vinzent Kevin Ortner, Berit Johansen, Kim Kilov, Alejandro Castillo Mondragón, Tore Duvold, Jesper Kihl, Felicity J Ashcroft, Astrid J Feuerherm, Charlotte Pind Laugesen, Maiken Lise Marcker Espersen, Ionela Manole, Ari Pall Isberg, Anders Daniel Andersen, Elin Rakvaag, John R Zibert, Merete Haedersdal

BMJ Open Oct 2022, 12 (10) e061012; DOI: 10.1136/bmjopen-2022-061012

Main menu

Dermatological Tumours

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatological Tumours

Pages